In the Weight Loss segment, the primary driver of market size is the application of the product, which is divided into four distinct categories. Clinical applications, representing roughly 30 % of revenue, encompass physician‑prescribed pharmaceuticals, injectable therapies, and medically supervised programs that require diagnostic oversight. Retail applications, the largest at about 45 %, include over‑the‑counter dietary supplements, thermogenic blends, and nutraceuticals sold through pharmacies, supermarkets, and e‑commerce platforms. Digital applications, accounting for 15 %, consist of subscription‑based mobile apps, virtual coaching services, and algorithm‑driven calorie‑tracking tools that supplement or replace traditional product use. Institutional applications, contributing 10 %, are deployed in hospitals, corporate wellness centers, and weight‑loss clinics where bundled services combine products with professional monitoring. Within each application, Types further differentiate sub‑categories: prescription drugs, OTC nutraceuticals, medical devices (e.g., gastric balloons), and surgical adjuncts. This layered taxonomy clarifies how each application channel fuels the overall Weight Loss and Weight Management Product segmentation and informs allocation of R&D and marketing resources.